UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 855

Sortiert nach

The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review and meta-analysis

Fertility and sterility, 2012-05, Vol.97 (5), p.1108-1114.e1

2012

Volltextzugriff (PDF)

Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial

Human reproduction (Oxford), 2015-05, Vol.30 (5), p.1188-1195

2015

Volltextzugriff (PDF)

Transcriptome analysis of flathead grey mullet (Mugil cephalus) ovarian development induced by recombinant gonadotropin hormones

Frontiers in physiology, 2022-11, Vol.13, p.1033445-1033445

2022

Volltextzugriff (PDF)

C-terminal peptide (hCTP) of human chorionic gonadotropin enhances in vivo biological activity of recombinant Japanese eel follicle-stimulating hormone and luteinizing hormone produced in FreeStyle 293-F cell lines

General and comparative endocrinology, 2021-05, Vol.306, p.113731-113731, Article 113731

2021

Volltextzugriff (PDF)

Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials

Reproductive biology and endocrinology, 2021-06, Vol.19 (1), p.1-91, Article 91

2021

Volltextzugriff (PDF)

Establishment of cell-lines stably expressing recombinant Japanese eel follicle-stimulating hormone and luteinizing hormone using CHO-DG44 cells: fully induced ovarian development at different modes

Frontiers in endocrinology (Lausanne), 2023-08, Vol.14, p.1201250

2023

Volltextzugriff (PDF)

Recombinant-luteinzing hormone supplementation in women during IVF/ICSI cycles with GNRH-antagonist protocol: A systematic review and meta-analysis

European journal of obstetrics & gynecology and reproductive biology, 2023-04, Vol.283, p.43-48

2023

Volltextzugriff (PDF)

The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis

Human reproduction update, 2012-03, Vol.18 (2), p.127-145

2012

Volltextzugriff (PDF)

Comparison between cycles of the same patients when using recombinant luteinizing hormone + recombinant follicle stimulating hormone (rFSH), human menopausal gonadotropin + rFSH and rFSH only

Archives of medical science, 2019-05, Vol.15 (3), p.673-679

2019

Volltextzugriff (PDF)

Recombinant LH supplementation during IVF cycles with a GnRH-antagonist in estimated poor responders: A cross-matched pilot investigation of the optimal daily dose and timing

Molecular medicine reports, 2015-09, Vol.12 (3), p.4219-4229

2015

Volltextzugriff (PDF)

Development of a reporter gene-based assay for the bioactivity determination of rhLH pharmaceutical products

Analytical biochemistry, 2024-03, Vol.686, p.115413-115413, Article 115413

2024

Volltextzugriff (PDF)

Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis

Reproductive biology and endocrinology, 2014-02, Vol.12 (1), p.17-17

2014

Volltextzugriff (PDF)

A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: A retrospective analysis

European journal of obstetrics & gynecology and reproductive biology, 2014-01, Vol.172, p.70-73

2014

Volltextzugriff (PDF)

Recombinant luteinizing hormone supplementation in assisted reproductive technology: a review of literature

Middle East Fertility Society journal, 2021-10, Vol.26 (1)

2021

Volltextzugriff (PDF)

Follicular fluid hormonal profile and cumulus cell gene expression in controlled ovarian hyperstimulation with recombinant FSH: effects of recombinant LH administration

Journal of assisted reproduction and genetics, 2012-12, Vol.29 (12), p.1381-1391

2012

Volltextzugriff (PDF)

Follicular development induced by recombinant luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in anovulatory women with LH and FSH deficiency: evidence of a threshold effect

Current medical research and opinion, 2008-10, Vol.24 (10), p.2785-2793

2008

Volltextzugriff (PDF)

Analysis of androgen receptor and anti-Müllerian hormone pathways in human granulosa cells under luteinizing hormone treatment

Reproductive biology and endocrinology, 2013-02, Vol.11 (1), p.11-11, Article 11

2013

Volltextzugriff (PDF)

Recombinant luteinizing hormone priming in multiple follicular stimulation for in-vitro fertilization in downregulated patients

Gynecological endocrinology, 2012-09, Vol.28 (9), p.674-677

2012

Volltextzugriff (PDF)

Recombinant luteinizing hormone priming in early follicular phase for women undergoing in vitro fertilization: Systematic review and meta-analysis

Journal of international medical research, 2014-04, Vol.42 (2), p.261-269

2014

Volltextzugriff (PDF)

Open-Label, Randomized, Two-Way, Crossover Study Assessing the Bioequivalence of the Liquid Formulation versus the Freeze-Dried Formulation of Recombinant Human FSH and Recombinant Human LH in a Fixed 2:1 Combination (Pergoveris ® ) in Pituitary-Suppressed Healthy Women

Frontiers in endocrinology (Lausanne), 2018-01, Vol.8, p.371-371

2018

Volltextzugriff (PDF)

Recombinant LH in ovarian stimulation

Reproductive biomedicine online, 2005-06, Vol.10 (6), p.774-785

2005

Volltextzugriff (PDF)

Lutropin alpha, recombinant human luteinizing hormone, for the stimulation of follicular development in profoundly LH-deficient hypogonadotropic hypogonadal women : a review

Biologics, 2009-01, Vol.3 (default), p.337-347

2009

Volltextzugriff (PDF)

A prospective, randomized comparison of ovulation induction using highly purified follicle-stimulating hormone alone and with recombinant human luteinizing hormone in in-vitro fertilization

Human reproduction (Oxford), 1999-09, Vol.14 (9), p.2230-2235

1999

Volltextzugriff (PDF)

Clinical assessment of human gonadotrophins produced by recombinant DNA technology

Human reproduction (Oxford), 1996-09, Vol.11 (Supplement-5), p.95-107

1996

Volltextzugriff (PDF)

Recombinant luteinizing hormone in assisted reproductive technology

Reviews in gynaecological practice, 2005-03, Vol.5 (1), p.45-50

2005

Volltextzugriff (PDF)

1 – 25 von 855

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(822)
Mit Volltextzugriff
(743)

Publikationsform

Artikel
(854)
Buchkapitel
(1)

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(711)
Life Sciences & Biomedicine
(681)
Humans
(572)
Female
(559)
Animals
(412)
Biological And Medical Sciences
(357)
Reproductive Biology
(267)
Endocrinology & Metabolism
(261)
Adult
(258)
Luteinizing Hormone - Blood
(249)
Recombinant Proteins - Pharmacology
(244)
Male
(240)
Obstetrics & Gynecology
(214)
Fundamental And Applied Biological Sciences. Psychology
(210)
Pregnancy
(210)
Luteinizing Hormone
(191)
Medical Sciences
(175)
Luteinizing Hormone - Pharmacology
(162)
Recombinant Proteins - Administration & Dosage
(149)
Follicle Stimulating Hormone - Blood
(145)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review and meta-analysis

Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial

Transcriptome analysis of flathead grey mullet (Mugil cephalus) ovarian development induced by recombinant gonadotropin hormones

C-terminal peptide (hCTP) of human chorionic gonadotropin enhances in vivo biological activity of recombinant Japanese eel follicle-stimulating hormone and luteinizing hormone produced in FreeStyle 293-F cell lines

Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials

Establishment of cell-lines stably expressing recombinant Japanese eel follicle-stimulating hormone and luteinizing hormone using CHO-DG44 cells: fully induced ovarian development at different modes

Recombinant-luteinzing hormone supplementation in women during IVF/ICSI cycles with GNRH-antagonist protocol: A systematic review and meta-analysis

The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis

Comparison between cycles of the same patients when using recombinant luteinizing hormone + recombinant follicle stimulating hormone (rFSH), human menopausal gonadotropin + rFSH and rFSH only

Recombinant LH supplementation during IVF cycles with a GnRH-antagonist in estimated poor responders: A cross-matched pilot investigation of the optimal daily dose and timing

Development of a reporter gene-based assay for the bioactivity determination of rhLH pharmaceutical products

Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis

A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: A retrospective analysis

Recombinant luteinizing hormone supplementation in assisted reproductive technology: a review of literature

Follicular fluid hormonal profile and cumulus cell gene expression in controlled ovarian hyperstimulation with recombinant FSH: effects of recombinant LH administration

Follicular development induced by recombinant luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in anovulatory women with LH and FSH deficiency: evidence of a threshold effect

Analysis of androgen receptor and anti-Müllerian hormone pathways in human granulosa cells under luteinizing hormone treatment

Recombinant luteinizing hormone priming in multiple follicular stimulation for in-vitro fertilization in downregulated patients

Recombinant luteinizing hormone priming in early follicular phase for women undergoing in vitro fertilization: Systematic review and meta-analysis

Open-Label, Randomized, Two-Way, Crossover Study Assessing the Bioequivalence of the Liquid Formulation versus the Freeze-Dried Formulation of Recombinant Human FSH and Recombinant Human LH in a Fixed 2:1 Combination (Pergoveris ® ) in Pituitary-Suppressed Healthy Women

Recombinant LH in ovarian stimulation

Lutropin alpha, recombinant human luteinizing hormone, for the stimulation of follicular development in profoundly LH-deficient hypogonadotropic hypogonadal women : a review

A prospective, randomized comparison of ovulation induction using highly purified follicle-stimulating hormone alone and with recombinant human luteinizing hormone in in-vitro fertilization

Clinical assessment of human gonadotrophins produced by recombinant DNA technology

Recombinant luteinizing hormone in assisted reproductive technology

Suchergebnisse filtern